Michael A. Narachi
2016
In 2016, Michael A. Narachi earned a total compensation of $5.2M as President, Chief Executive Officer and Member of the Board of Directors at Orexigen Therapeutics, a 48% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $458,756 |
|---|---|
| Option Awards | $3,202,700 |
| Salary | $679,639 |
| Stock Awards | $864,000 |
| Other | $8,466 |
| Total | $5,213,561 |
Narachi received $3.2M in option awards, accounting for 61% of the total pay in 2016.
Narachi also received $458.8K in non-equity incentive plan, $679.6K in salary, $864K in stock awards and $8.5K in other compensation.
Rankings
In 2016, Michael A. Narachi's compensation ranked 1,514th out of 14,075 executives tracked by ExecPay. In other words, Narachi earned more than 89.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,514 out of 14,075 | 89th |
Division Manufacturing | 521 out of 5,489 | 91st |
Major group Chemicals And Allied Products | 147 out of 1,895 | 92nd |
Industry group Drugs | 100 out of 1,538 | 94th |
Industry Pharmaceutical Preparations | 80 out of 1,176 | 93rd |
Source: SEC filing on May 30, 2017.
Narachi's colleagues
We found two more compensation records of executives who worked with Michael A. Narachi at Orexigen Therapeutics in 2016.